[A case of a patient with advanced rectal cancer and urinary bladder fistula surviving for 6 years after chemoradiotherapy without surgery]

Gan To Kagaku Ryoho. 2014 Aug;41(8):1017-20.
[Article in Japanese]

Abstract

A 60-year-old man with advanced rectal cancer and urinary bladder fistula received preoperative chemoradiotherapy with S-1(120mg/m / 2day)on weekdays and concurrent radiotherapy(65 Gy). After chemoradiotherapy, the clinical symptoms resolved and the tumor shrunk, as observed on endoscopic and radiologic examinations. However, remnant cancer was suspected; therefore, modified oxaliplatin, 5-fluorouracil, and Leucovorin(mFOLFOX6)therapy was initiated, although it was stopped after 3 cycles because of numbness in the lower extremities. Finally, clinical and pathological complete response(CR) was achieved by administering additional doses of S-1 for approximately 1 year after treatment initiation; CR was confirmed by using endoscopy and computed tomography(CT), and there has been no recurrence for 6 years. This case suggests that treatment without surgery is a viable alternative for advanced rectal cancer with pathological CR after chemoradiotherapy.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antimetabolites, Antineoplastic / therapeutic use*
  • Chemoradiotherapy*
  • Drug Combinations
  • Humans
  • Male
  • Middle Aged
  • Oxonic Acid / therapeutic use*
  • Rectal Neoplasms / complications
  • Rectal Neoplasms / therapy*
  • Remission Induction
  • Tegafur / therapeutic use*
  • Time Factors
  • Urinary Bladder Fistula / etiology*

Substances

  • Antimetabolites, Antineoplastic
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid